The Buffalo Neuroimaging Analysis Center (BNAC) offer s a variety of magnetic resonance imaging (MRI) measures of the brain, spinal cord, and optic nerve for research studies and clinical trials. BNAC also compiles individual quantitative MRI reports for research purposes.
The BNAC computes a variety of other conventional and non-conventional quantitative brain MRI measurements: estimates of T2-, T1-, gadolinium-enhancing and confluence lesion volumes, and calculation of global and regional magnetization transfer, diffusion weighted and tensor, magnetic resonance spectroscopy, functional MRI (fMRI), perfusion and atrophy MRI indices. In addition, BNAC has recently expanded its research to cerebrospinal fluid, susceptibility-weigted imaging, spinal cord and optic nerve imaging.
Our newest product is called NeuroSTREAM. Brain atrophy is a critical component of multiple sclerosis (MS) at all stages of the disease. Its importance is now widely-recognized and it is becoming a key endpoint in many trials. Early work with the NeuroSTREAM software showed that atrophy is measurable using routine clinical scans. We have developed and validated a new, robust algorithm for measuring laterial ventricular volume (LVV) on clinical-quality FLAIRE images, an MRI sequence performed as part of most diagnostic and monitoring examinations for MS. The NeuroSTREAM software offers a user-friendly, cloud-based software platform to remove infrastructure barriers. If you have a need for this service or would like a quote, please contact BNAC at 1-716-859-7040.